Magnus Dahlman is specialized in intellectual property law. He represents large and small clients in a wide variety of complex intellectual property matters, providing strategic advice on identifying, developing, protecting and commercializing intellectual property rights.
Magnus is an experienced litigator and has litigated several landmark cases especially within life sciences and tech patents but also trademark, trade secrets and copyright. Magnus is also regularly handling regulatory issues in the life science and telecom field and issues relating to various kinds of certifications.
Magnus has been ranked by several ranking insitutes in the categories Patent Contentious and Intellectual Property and has also recently been acting as counsel in the first mock trial under the UPC rules in the Nordic Baltic regional division arranged by the Swedish Department of Justice.
Magnus is a co-author to the first and second edition of Hasselblatt (ed.) ”Community Trade Mark Regulation – English Language Commentary” and Hasselblatt (ed.) ”Community Design Regulation – English language commentary” published by the German publishing house C. H Beck Hart Nomos.
Master Intellectual Property Rights (2003)
EUs Machine Directive and CE-marking (2002)
Advokatbyrån Gulliksson (2017-2018)
Setterwalls Advokatbyrå (2007-2017)
District Court of Malmö (2005-2007)
Sony Ericsson Mobile Communications AB (2003-2005)
Intellectual property rights, litigation, regulatory
Pharma, Life Sciences, telecom
Partner, Member of the Swedish Bar Association (Advokat)
Swedish Bar Association (2010)
AIPPI (Member of Standing Committee Q242 Pharma & Biotechnology)
Recommended in Who’s Who Legal, global guide for patents
“Magnus Dahlman and Mattias Malmstedt are simply top-tier litigators, with a solid understanding of their clients businesses. The team is very competent and business minded. Straightforward advice is combined with an academic touch.”
IAM Patent 1000 (2020):
“A premier choice for life science briefs and a tough adversary, Magnus has a keen eye for detail and calmly puts forth convincing arguments.”
IAM Patent 1000 (2019):
“Dahlman […] is a repository of unshakeable trust for generic drug companies. ‘He understands the industry and is an experienced, calm, tactical and convincing litigator.'”
IAM Patent 1000 (2018):
“The outfit has brought on board life sciences doyen Magnus Dahlman. “Magnus hasn’t been there long”, one peer remarks, “but he has already worked with us in litigation on numerous occasions as well as having been an instrumental adviser to his clients on the commercial aspects of their businesses”
IAM Patent 1000 (2017):
“He presents well, is clear in his arguments, has very sound judgement and shows plenty of enthusiasm for the law.”
MIP IP Stars (2016, 2017 & 2018)